Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...

ESTERO, FLORIDA / ACCESS Newswire / September 3, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, ...

TxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clots This rapid inhibition is critical during suspected heart attacks, ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

Among adults with chronic rhinosinusitis with nasal polyps, asthma and NSAID-exacerbated respiratory disease, aspirin after desensitization does not benefit most patients vs. placebo, according to ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

ESTERO, FL - Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a small-cap pharmaceutical company with a current market capitalization of $28.5 million, announced Wednesday that its sublingual aspirin ...

ESC Guidelines recommend dual antiplatelet therapy (DAPT) for patients with acute coronary syndrome (ACS) who undergo coronary artery bypass grafting (CABG), although evidence from large, randomized ...

A medicine called clopidogrel may take over from aspirin’s widespread use as a blood thinner to stop heart attacks and strokes. But as both aspirin and clopidogrel can trigger excess bleeding and ...

The Bundesliga side have confirmed the signing of Vazquez from Real Madrid, with the Spain international penning a contract until 2027. The right-back reportedly underwent a medical in secret ahead of ...

Recommended external contentVideoWe need your consent to show you content our Editorial team embedded from Video. You can toggle this (and all other embeds from Video across goal.com) on with one ...